Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2026-01-26 @ 4:04 PM
Study NCT ID:
NCT06515418
Status:
TERMINATED
Last Update Posted:
2025-03-13
First Post:
2024-07-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
Sponsor:
BioAge Labs, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Obesity | View |